283 related articles for article (PubMed ID: 30541778)
1. Vitamin E Increases Antimicrobial Sensitivity by Inhibiting Bacterial Lipocalin Antibiotic Binding.
Naguib MM; Valvano MA
mSphere; 2018 Dec; 3(6):. PubMed ID: 30541778
[No Abstract] [Full Text] [Related]
2. Antibiotic Capture by Bacterial Lipocalins Uncovers an Extracellular Mechanism of Intrinsic Antibiotic Resistance.
El-Halfawy OM; Klett J; Ingram RJ; Loutet SA; Murphy ME; Martín-Santamaría S; Valvano MA
mBio; 2017 Mar; 8(2):. PubMed ID: 28292982
[TBL] [Abstract][Full Text] [Related]
3. Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients.
Papp-Wallace KM; Becka SA; Zeiser ET; Ohuchi N; Mojica MF; Gatta JA; Falleni M; Tosi D; Borghi E; Winkler ML; Wilson BM; LiPuma JJ; Nukaga M; Bonomo RA
ACS Infect Dis; 2017 Jul; 3(7):502-511. PubMed ID: 28264560
[TBL] [Abstract][Full Text] [Related]
4. The antibacterial properties of docosahexaenoic omega-3 fatty acid against the cystic fibrosis multiresistant pathogen Burkholderia cenocepacia.
Mil-Homens D; Bernardes N; Fialho AM
FEMS Microbiol Lett; 2012 Mar; 328(1):61-9. PubMed ID: 22150831
[TBL] [Abstract][Full Text] [Related]
5. Quantitative proteomics (2-D DIGE) reveals molecular strategies employed by Burkholderia cenocepacia to adapt to the airways of cystic fibrosis patients under antimicrobial therapy.
Madeira A; Santos PM; Coutinho CP; Pinto-de-Oliveira A; Sá-Correia I
Proteomics; 2011 Apr; 11(7):1313-28. PubMed ID: 21337515
[TBL] [Abstract][Full Text] [Related]
6. Molecular approaches to pathogenesis study of Burkholderia cenocepacia, an important cystic fibrosis opportunistic bacterium.
Bazzini S; Udine C; Riccardi G
Appl Microbiol Biotechnol; 2011 Dec; 92(5):887-95. PubMed ID: 21997606
[TBL] [Abstract][Full Text] [Related]
7. An evolutionary conserved detoxification system for membrane lipid-derived peroxyl radicals in Gram-negative bacteria.
Naguib M; Feldman N; Zarodkiewicz P; Shropshire H; Biamis C; El-Halfawy OM; McCain J; Dezanet C; Décout JL; Chen Y; Cosa G; Valvano MA
PLoS Biol; 2022 May; 20(5):e3001610. PubMed ID: 35580139
[TBL] [Abstract][Full Text] [Related]
8. Putrescine reduces antibiotic-induced oxidative stress as a mechanism of modulation of antibiotic resistance in Burkholderia cenocepacia.
El-Halfawy OM; Valvano MA
Antimicrob Agents Chemother; 2014 Jul; 58(7):4162-71. PubMed ID: 24820075
[TBL] [Abstract][Full Text] [Related]
9. Targeting the Nonmevalonate Pathway in Burkholderia cenocepacia Increases Susceptibility to Certain β-Lactam Antibiotics.
Sass A; Everaert A; Van Acker H; Van den Driessche F; Coenye T
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439968
[TBL] [Abstract][Full Text] [Related]
10. Chemical communication of antibiotic resistance by a highly resistant subpopulation of bacterial cells.
El-Halfawy OM; Valvano MA
PLoS One; 2013; 8(7):e68874. PubMed ID: 23844246
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models.
Van den Driessche F; Vanhoutte B; Brackman G; Crabbé A; Rigole P; Vercruysse J; Verstraete G; Cappoen D; Vervaet C; Cos P; Coenye T
PLoS One; 2017; 12(3):e0172723. PubMed ID: 28248999
[TBL] [Abstract][Full Text] [Related]
12. Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia.
Scoffone VC; Barbieri G; Buroni S; Scarselli M; Pizza M; Rappuoli R; Riccardi G
Trends Microbiol; 2020 Apr; 28(4):315-326. PubMed ID: 31932141
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis.
Sass A; Marchbank A; Tullis E; Lipuma JJ; Mahenthiralingam E
BMC Genomics; 2011 Jul; 12():373. PubMed ID: 21781329
[TBL] [Abstract][Full Text] [Related]
14. Competitive Fitness of Essential Gene Knockdowns Reveals a Broad-Spectrum Antibacterial Inhibitor of the Cell Division Protein FtsZ.
Hogan AM; Scoffone VC; Makarov V; Gislason AS; Tesfu H; Stietz MS; Brassinga AKC; Domaratzki M; Li X; Azzalin A; Biggiogera M; Riabova O; Monakhova N; Chiarelli LR; Riccardi G; Buroni S; Cardona ST
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297366
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic resistance in Burkholderia species.
Rhodes KA; Schweizer HP
Drug Resist Updat; 2016 Sep; 28():82-90. PubMed ID: 27620956
[TBL] [Abstract][Full Text] [Related]
16. Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.
Furniss RCD; Kaderabkova N; Barker D; Bernal P; Maslova E; Antwi AAA; McNeil HE; Pugh HL; Dortet L; Blair JMA; Larrouy-Maumus G; McCarthy RR; Gonzalez D; Mavridou DAI
Elife; 2022 Jan; 11():. PubMed ID: 35025730
[TBL] [Abstract][Full Text] [Related]
17. Acidic pH modulates
Morales LD; Av-Gay Y; Murphy MEP
Microbiol Spectr; 2023 Dec; 11(6):e0273123. PubMed ID: 37966209
[No Abstract] [Full Text] [Related]
18. Burkholderia cepacia complex Phage-Antibiotic Synergy (PAS): antibiotics stimulate lytic phage activity.
Kamal F; Dennis JJ
Appl Environ Microbiol; 2015 Feb; 81(3):1132-8. PubMed ID: 25452284
[TBL] [Abstract][Full Text] [Related]
19. Fish oils against Burkholderia and Pseudomonas aeruginosa: in vitro efficacy and their therapeutic and prophylactic effects on infected Galleria mellonella larvae.
Mil-Homens D; Ferreira-Dias S; Fialho AM
J Appl Microbiol; 2016 Jun; 120(6):1509-19. PubMed ID: 27012860
[TBL] [Abstract][Full Text] [Related]
20. Bactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepacia.
Halwani M; Mugabe C; Azghani AO; Lafrenie RM; Kumar A; Omri A
J Antimicrob Chemother; 2007 Oct; 60(4):760-9. PubMed ID: 17673475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
